- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 3/04 - Anorexiants; Antiobesity agents
Patent holdings for IPC class A61P 3/04
Total number of patents in this class: 6730
10-year publication summary
|
264
|
244
|
227
|
339
|
440
|
442
|
555
|
540
|
479
|
140
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
96 |
| Shionogi & Co., Ltd. | 914 |
73 |
| Novo Nordisk A/S | 2324 |
61 |
| AstraZeneca AB | 3042 |
60 |
| Janssen Pharmaceutica N.V. | 3839 |
60 |
| Boehringer Ingelheim International GmbH | 4629 |
59 |
| Eli Lilly and Company | 3645 |
59 |
| Daiichi Sankyo Company, Limited | 1829 |
50 |
| Pfizer Inc. | 3322 |
49 |
| Société des Produits Nestlé S.A. | 9672 |
48 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
46 |
| LG Chem, Ltd. | 17205 |
44 |
| F. Hoffmann-La Roche AG | 7958 |
43 |
| Nestec S.A. | 2777 |
42 |
| Ajinomoto Co., Inc. | 2337 |
41 |
| Novartis AG | 11238 |
40 |
| Bristol-myers Squibb Company | 5080 |
38 |
| Banyu Pharmaceutical Co., Ltd. | 107 |
38 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
36 |
| Laboratorios Del Dr. Esteve, S.A. | 239 |
34 |
| Other owners | 5713 |